Kenneth S Kornman insider trades: Interleukin Genetics (ILIU) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 29, 2016 | ILIU | ↑ Buy | 25,150 | $0.10 | $2K | Direct | Aug 1, 2016 (3d) |
| Nov 19, 2008 | ILI | ↑ Buy | 10,000 | $0.45 | $5K | Direct | Nov 20, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kenneth S Kornman's insider trades
Kenneth S Kornman is President and CSO at Interleukin Genetics (ILIU). Since Nov 19, 2008, Kenneth has reported 2 open-market purchases worth $7K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (13 filings), gifts (2 filings), other transactions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ILIU insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.